27 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/13/26 16:20
2/13/26
QDELQuidelortho CorpHealthDiagnIn Vitro & In Vivo DiagnosticStrobeck MatthewCAD1P24023.960101483D
2/13/26 12:44
2/13/26
QDELQuidelortho CorpHealthDiagnIn Vitro & In Vivo DiagnosticBusky Joseph M.CAOCFO2P20425.07081952I
2/13/26 10:43
2/13/26
QDELQuidelortho CorpHealthDiagnIn Vitro & In Vivo DiagnosticBlaser Brian J.CAOP,CEO2P75022.0403410965I
2/12/26 19:49
2/10/26
IMDXInsight Molecular Diagnostics Inc.CAHealthDiagnIn Vitro & In Vivo DiagnosticBroadwood Partners, L.P.NYT1P.d3,0005.750522223,864M
2/11/26 17:01
2/9/26
IDXXIdexx Laboratories Inc /DeDEHealthDiagnIn Vitro & In Vivo DiagnosticFennell GeorgeMEOEVP2M.dm8,207339.6102410D
2/11/26 17:01
2/10/26
IDXXIdexx Laboratories Inc /DeDEHealthDiagnIn Vitro & In Vivo DiagnosticFennell GeorgeMEOEVP2S.dm-8,207339.610-2410D
2/2/26 20:51
1/30/26
IONSIonis Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticHougen Elizabeth LCAOEVP,Fina3S.d-1,55431.940-49133D
2/2/26 16:36
1/26/26
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticNassif MikhealMIDOCEO2P.m29.4900381I
1/7/26 16:05
1/5/26
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEO3S.dm-1,5518.580-1811,106D
1/7/26 16:05
1/5/26
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSchultes Birgit CMAOEVP,Chie1S-789.210-999D
1/7/26 16:05
1/5/26
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticBasta JamesMAOEVP,GC1S-969.210-10102D
1/7/26 16:05
1/5/26
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticCohen Fred EMAD1P1,4039.350150261207D
1/7/26 16:04
1/5/26
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLebwohl DavidMAOEVP,Chie1S-1109.210-12121D
1/7/26 16:03
1/5/26
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticClark ElianaMAOEVP,Chie1S-889.210-1087D
1/7/26 16:02
1/5/26
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticDulac Edward J IIIMAOEVP,CFO1S-599.210-6100D
1/7/26 16:01
1/5/26
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticDube Michael PMAOVP,Chief1S-289.210-352D
1/6/26 16:23
1/2/26
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartin Samuel BatesNJOSVP,CFO1M.d5010.38051733D
12/17/25 16:06
12/15/25
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticPepin RonaldNJOSVP,CBO1M.d1065.47019999%20D
12/10/25 18:37
12/10/25
QDELQuidelortho CorpHealthDiagnIn Vitro & In Vivo DiagnosticRhoads Ann DCAD1P2128.2701515D
12/8/25 16:20
12/4/25
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticJimenez Freddy A.NJOSVP,GC1S-12129.100-431D
12/4/25 16:11
12/3/25
ICCCImmucell Corp /De/DEHealthDiagnIn Vitro & In Vivo DiagnosticTe Boekhorst Paul Francis OlivierMEDOP,CEO2P.m805.0701610D
12/2/25 11:45
12/1/25
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticNaemura David H.MIOFormer C1M.d775.980131790D
12/1/25 16:33
11/26/25
QDELQuidelortho CorpHealthDiagnIn Vitro & In Vivo DiagnosticWilkins Joseph D Jr.CAD1P1027.9500312D
11/28/25 08:12
11/25/25
ICCCImmucell Corp /De/DEHealthDiagnIn Vitro & In Vivo DiagnosticTomsche David ScottMED1P164.76033131M
11/25/25 16:16
11/25/25
QDELQuidelortho CorpHealthDiagnIn Vitro & In Vivo DiagnosticWidder Kenneth JCAD2M.d22220.140114237D
11/25/25 16:16
11/25/25
QDELQuidelortho CorpHealthDiagnIn Vitro & In Vivo DiagnosticWidder Kenneth JCAD2S.d-22220.140-1137D
11/24/25 16:09
11/21/25
QDELQuidelortho CorpHealthDiagnIn Vitro & In Vivo DiagnosticPolan Mary Lake Ph DCAD1P2222.4301330D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact